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Abstract
We study the endogenous relationship between health care, life expectancy and output
in a modiﬁed neoclassical growth model. While health care competes resources away from
goods production, it prolongs life expectancy which in turn leads to higher capital accumu-
lation. We show that savings and health care are complements in equilibrium, with both
rising with economic development. Our model is therefore consistent with several stylized
facts, namely, (i) countries spend more on health care as they prosper, (ii) individuals in
rich countries tend to live longer, and (iii) population aging is more pronounced in rich
countries. Moreover, through simulation, health care and health production technology are
found to be growth and welfare enhancing.
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With few exceptions, we have observed consistent and steady rises over time of health care
expenditure, both in absolute terms and as percentages of GDP, in almost all countries in
the world. The total health care expenditures among EMU countries, for example, have
reached an average around 9% — a signiﬁcant share — of GDP in recent years (see Table
1).1 It is therefore not surprising that health care issues and policies have attracted growing
attention in many, albeit mostly developed, countries. From macroeconomic point of view, both
time-series and cross-country data have been suggesting a rather robust positive correlation
between health care spending and per capita GDP. Simultaneously, we have also observed
in the same process striking rises in longevity and transitions of demographic structure in
economies across diﬀerent stages of development (see again, for example, Table 1). Despite the
seemingly overwhelming empirical evidence, there has been little theoretical work on modelling
the explicit linkage between health care spending, life expectancy, and economic performance.
In this paper, we formalize within a simple growth framework a mechanism through which
health care expenditure and life expectancy endogenously evolve with economic development.
In so doing, we intend to address the several patterns exhibited in Table 1 and, more generally,
to explore some macro implications of health care in the process of economic development.
[Insert Table 1 about here]
In the growth literature, health usually plays a passive and dormant role as it is often
proxied by, or identiﬁed with, life expectancy, and hence the study of its economic relevance
is largely limited to investigating the growth implications of life expectancy. Along this line
of research, Kotlikoﬀ (1989) ﬁnds that life-extension is likely to raise capital and output per
worker, as well as welfare. In an endogenous growth model with intergenerational trade, Ehrlich
and Lui (1991) argue that an increase in longevity can stimulate growth through motivating
human capital investment in future generations. The cross-country evidence presented in Barro
(1997) also suggests that both the education attainment and the life expectancy are positively
correlated with the growth rate of real GDP per capita. Indeed, the simulation of a calibrated
model in Kalemli-Ozcan et al (2000) shows a signiﬁcant role of mortality decline in raising
human capital investment during the process of economic growth. In these studies, however,
1This table summarizes some key indicators of our interest from the World Development Indicators 2001
published by the World Bank.
1life expectancy (or mortality) is treated as an exogenous parameter, and the linkage between
health investment and life expectancy is not considered.
In this paper, we study the inter-dependence of health care/investment, life expectancy,
and economic development in an overlapping generations model of two-period lived agents.
Contrasting with the conventional model, we assume that individuals only survive to the second
period (retirement age) with a probability that is increasing in their health capital. Following
Grossman (1972), the stock of health capital can be maintained and/or augmented through
purposeful health investment. In this environment, health investment gives rise to two opposing
eﬀects on capital accumulation and hence growth: While health investment directly diverts
resources away from productive use, it results in a prolonged life expectancy which in turn
encourages capital formation. Despite the direct competition for available resources, we show
that aggregate savings/capital and health investment are complements along an equilibrium
path — agents will optimally choose to increase or decrease savings and health spending at the
same time. In our parametric example, we also show that health care is indeed a normal good
under plausible parameter values. In addition, we show through simulation that the steady-
state output, per capita income, and welfare in our model are consistently higher than those in
ab e n c h m a r km o d e lw h e r et h er o l eo fh e a l t hc a r ei nl i f ee x t e n s i o ni sa b s e n t .T h i si m p l i e st h a t
health care is potentially a growth-promoting factor and the usual models that neglect health
care tend to either under estimate growth/output or over estimate the growth impacts of other
factors. Our simulation results further suggest that advancement in medical technology is also
likely to raise steady-state output and welfare.
An important feature of our model is that life expectancy evolves endogenously with health
care spending along an equilibrium path. This endogenous treatment of life expectancy in
our model allows for the following implications on the demographic structure that are largely
consistent with the stylized facts. In our model, health care spending and hence life expectancy
are positively correlated with income. This suggests that, from the time-series point of view,
life expectancy tends to rise as a country develops and, from the cross-country point of view,
high income countries tend to have higher life expectancies than low income countries. These
implications seem to accord well with the evidence in, for instance, Cochrane et al (1978),
Parkin et al (1987), Gerdthan et al (1992), and Table 1. In addition, our model is also
consistent with the observation that the percentage of population in retirement is higher in
developed countries than it is in developing countries, as indicated in Table 1.
2Health investment aﬀects capital accumulation and growth in our model through changing
life expectancy. It has been argued that an increase in life expectancy might exert a negative
impact on per capita income, as extending lives beyond productive years would only lead to
a greater population dependency ratio and a smaller per capita output. We turn this concern
on its head in the present model: An increase in life expectancy takes precisely the form of
a greater percentage of agents surviving to the second period of their lives during which they
are no longer productive. Despite this age-structure eﬀect, increases in life expectancy in our
model are found to be associated with higher levels of per capita GDP. This suggests that,
as life expectancy rises, the positive impact on per capita income arising from higher savings
tends to be large enough to outweigh the negative impact arising from a greater proportion of
unproductive population. This implication is therefore in agreement with the recent studies by
Lee et al (2000) and Bloom et al (2002), which found signiﬁcant positive relationships between
savings and life expectancy in cross-country data.
Our paper is also related to the following studies. In eﬀorts to endogenize longevity, Black-
burn and Cipriani (2002) obtain multiple equilibria with varying degrees of longevity and
growth rate by assuming an externality from human capital. Philipson and Becker (1998)
present a partial-equilibrium analysis in which longevity and health investment are inﬂuenced
by the availability of age-contingent claims. Using a diﬀerent approach than ours, the recent
work by van Zon and Muysken (2001) oﬀers a rare example that explicitly incorporates health
into an endogenous growth framework.2 Moreover, our notion of health investment is akin to
that of “life protection” in the models of Grossman (1972), Ehrlich and Chuma (1990), and
Ehrlich (2000) on demand for longevity. Their models are, however, largely partial equilibrium
in nature and not focused on macro development issues. Finally, while Blackburn and Cipriani
(2002) also uses a survival probability from one period to the next, their survival probability
is assumed to be aﬀected by the level of human capital, not health investment, and hence
the explicit role of health care in life extension is absent. To summarize, comparing with the
existing literature, our paper introduces a dynamic general equilibrium model in which the
macroeconomic implications of health care can be conveniently analyzed.
2In van Zon and Muysken (2001), the authors extend the basic Lucas (1988) framework to an environment in
which health investment competes for time with activities in human capital accumulation and goods production.
In general, despite the productivity- and welfare-enhancing role of health, they ﬁnd that health correlates
negatively with growth. In contrast, we study a decentralized model with overlapping generations where health
production competes for output with consumption. In our model, health tends to be positively associated with
capital accumulation and hence output.
3The rest of the paper proceeds as follows. We outline the general model and discuss the
equilibrium conditions in Section 2. In Section 3, for illustration purposes, we will study how
health care relates to growth by using an explicit parametric example and simulation. Then,
we oﬀer some concluding remarks in Section 4. Finally, some technical proofs are contained in
the appendix.
2T h e M o d e l
We consider a two-period overlapping generations model in which a continuum of identical
agents with mass one is born in each period. Agents born in period t live to the old age (the
second period) only with a probability pt that is determined by their health stock.3 Following
Grossman (1972), agents are assumed to be able to produce health stock by purposeful health
investment, according to a health production function. Suppose agents of all generations are
endowed ex ante with an initial health capital h0 in the ﬁrst period of their lives. The health
stock of a young agent in period t is then described by the following equation
ht = h0 + h(mt) (1)
where h(mt) measures the health creation by health investment of mt and satisﬁes h (·) > 0,
limm→0 h (m)=+ ∞, and limm→∞h (m)=0 . Health investment in our model can be broadly
deﬁned as all spending and activities related to improving the health stock of an agent, which
includes but is not limited to spending on medical products and services. For a concrete
and reasonable approximation, we later use health care expenditure as the proxy for health
investment in our discussion on calibration and simulation. Therefore, without confusion, we
use the terms of ‘health investment’ and ‘health care’ interchangeably throughout the paper.
We postulate that the probability of a generation t agent surviving to the second period is
increasing in his health capital and is given by pt = h p(ht). This survival probability function can
be rewritten, using (1), as pt = h p(ht)=p(mt). Naturally, the function p(·) can be interpreted
as some sort of production function whereby resources are spent to “produce” chances of
survival into old age. As such, p(·) can be expected to exhibit the usual properties of a
production function. Speciﬁcally, for analytical simplicity, we assume the following conditions:
3This surviving probability into the second period of an agent’s life, during which the agent no longer works,
can be conveniently thought as the surviving probability to age 65, the normal retirement age, in Table 1. This
probability is obviously related negatively to the mortality rate and positively to the life expectancy of the
population.
40 ≤ p(·) ≤ 1, p (·) > 0, p  (·) < 0,l i m m→0p (m)=+ ∞, and limm→∞p (m)=0 .4 Finally, the
health stock of an agent will drop to zero and the agent dies by the end of the second period
with certainty.
Agents’ preferences are identical for all generations. The preferences in the ﬁrst period are
given by a strictly increasing and concave utility function u(c), satisfying the Inada condition
at zero. The utility function from the second-period consumption is given by v(c) that satisﬁes
the similar conditions and v(·) ≥ 0.5 Therefore, for an individual agent of generation t,h i s
expected life-time utility is given by
U(ct
t,c t
t+1)=u(ct
t)+ptv(ct
t+1) (2)
where ct
t and ct
t+1 are the consumption levels of a generation t agent in periods t and t +1 ,
respectively.
Agents of all generations are endowed with one unit of labor when they are young, which
is then supplied inelastically in the labor market. By supplying labor, an agent who is born in
period t earns a market wage rate, wt,i nt h eﬁrst period of his life. Having earned wt when
young, the agent has to decide on his ﬁrst-period consumption, ct
t; his amount of savings, st;
and the amount of health care he wishes to purchase, mt. Savings in period t,w h i c hb e c o m et h e
physical capital in period t+1, yield a real rate of return of rt. Since not all agents survive to
the second period, we assume that there is a perfectly competitive and actuarially fair annuity
market through which the total returns from the savings of those who are deceased before
reaching their old age will be equally redistributed, in the form of a lump-sum transfer, to
the remaining survivors within the same generation. Let Pt ∈ [0,1] denote the proportion of
generation t agents, at the aggregate level, who survive to the second period. It is easy to see
that the lump-sum transfer to a survived old agent is
τt =
(1 − Pt)st(1 + rt)
Pt
. (3)
Because all agents are identical and the population of young agents is normalized to one,
Pt = pt = p(mt). (4)
4To gain some understanding of the shape of p(·), we have examined the cross-country relationship between
survival rate to age 65, or life expectancy, and health expenditure per capita using the data compiled in the
World Development Indicators 2001 by the World Bank. The scatter plot based on the empirical data strongly
support our theoretical speciﬁcation of p(·).
5Normally, the utility function is not required to be positive. However, the possibility of death in the second
period introduces one technical problem: If the utility from consumption can be negative (such as the case with
logarithmic utility function) and the utility in the event of death is normalized to zero, agents then could prefer
death to surviving. To avoid such a perverse situation, we require that the second period utility function be
positive.
5For the same reason, throughout the paper, we will not distinguish variables at the individual
level from that at the aggregate level.
Therefore, the optimization problem of a representative agent of generation t is as follows.
Taking wt, rt, and τt as given,6 the agent chooses st and mt in order to maximize the expected
life-time utility given in (2), subject to the following constraints:
ct
t = wt − st − mt (5)
ct
t+1 = st(1 + rt)+τt (6)
pt = p(mt) (7)
On the production side, the aggregate output is characterized by a constant return to
scale production function in capital and labor, so that the per-capita output can be written as
yt = f(kt), where kt measures the capital-labor ratio and f(·) is strictly increasing and concave.
Labor and capital are assumed to be priced competitively according to their respective marginal
productivities. Therefore, the wage rate and the rate of return on capital are given by
wt = f(kt) − ktf (kt) (8)
1+rt = f (kt+1) (9)
Without loss of generality, capital is assumed to depreciate completely in every period so that
kt+1 = st. (10)
Finally, the initial capital stock is k0 > 0. This completes the description of the model.
For the maximization problem of generation t agents, the ﬁrst order conditions with respect
to st and mt are, respectively,
u (ct
t)=p(mt)v (ct
t+1)(1 + rt) (11)
and
u (ct
t)=p (mt)v(ct
t+1) (12)
where ct
t and ct
t+1 are given in (5) and (6). Equation (11) is the usual condition that requires
the marginal rate of substitution between current and future consumption to be equal to the
6Since the transfer is assumed to be in a lump sum, agents view τt as a number that is independent of
their individual savings decisions. However, our entire analysis goes through if agents are assumed to take into
account the eﬀect of their individual savings decisions on the amount of transfers deﬁned by (3).
6expected return on savings. Equation (12) captures the trade oﬀ between the marginal cost
and marginal beneﬁt of health care spending. By investing in health care, the agent foregoes
the current consumption in exchange for an increased chance of survival in the second period.
Combining (11) and (12), we obtain
p(mt)v (ct
t+1)(1 + rt)=p (mt)v(ct
t+1). (13)
Equation (13) gives the condition on how to allocate a marginal dollar towards savings versus
health care. If a marginal dollar is allocate towards savings, the agent gains marginal utility
from the expected gross return of the dollar. On the other hand, if the same dollar is allocated
towards health care, it increases the chance of actually enjoying future consumption by p (mt).
Therefore, in equilibrium an agent will allocate the marginal dollar towards health care such
that the utility gain from health creation just equals the utility loss from having less expected
second-period income.
Therefore, a dynamic equilibrium path of the economy is characterized by a sequence of
{mt,s t,k t}+∞
t=0 that satisﬁes the ﬁrst order conditions (11) and (12), plus that equations (3)
— (10) hold. Hence, in equilibrium, the ﬁrst-period and second-period consumptions can be
rewritten as
ct
t = f(kt) − ktf (kt) − st − mt (14)
ct
t+1 =
stf (st)
p(mt)
. (15)
Before we proceed, we make the following assumption.
Assumption A. f (k)+kf  (k) > 0.
Assumption A means that at the total return of capital increases as the amount of capital
in production increases. This is true, for example, for a Cobb-Douglas or a CES production
function. Under this assumption, we prove in the appendix that the following result holds.
Proposition 1 In equilibrium, the amount of savings st and the health investment mt are
strictly positively related.
Proposition 1 implies that, despite the direct competition for resources, savings/capital and
health investment are complements in equilibrium. The reason that in our model agents save
more when health investment increases is two fold. As a higher health investment prolongs
7an agent’s life expectancy, he has more incentive to save for the old-age income. Secondly, as
health investment becomes higher, its marginal beneﬁt diminishes (since p(·) is concave) and
hence saving becomes a more attractive alternative.
Proposition 1 is also suggestive of the relationship between health care in economic devel-
opment. Based on Proposition 1, one may reasonably conjecture that as the economy develops
a g e n t sw i l ls p e n dm o r eo nh e a l t hc a r e ,w h i c hi nt u r nl e a d st om o r es a v i n g st h a tc o u l df u e l
further growth. Unfortunately, we could not establish such kind of result analytically in our
model with the general functional forms. To gain better understanding of the role of health
care, we specify in the following section the explicit functional forms in the model.
3 Health Care and Economic Growth
In this section, we assume the following functions:
u(c)=v(c)=
c1−γ
1 − γ
(16)
f(k)=Akα (17)
p(mt)=p0 + p
u
mt
1+mt
(18)
where the restrictions on the exogenous variables are A>0, α, γ,p 0, p ∈ (0,1) and p0+p ≤ 1.
The functional forms for the utility and output production are fairly standard.7 The health
production as embodied in the function p(·) allows for the following interpretations. The
survival probability will be equal to p0, which is strictly between 0 and 1,i fa na g e n ts p e n d s
nothing on health maintenance. This default survival probability presumably reﬂects the
innate health capital that everyone is born with. However, an agent can augment his chances
of survival by purchasing and consuming health services, according to an increasing, concave
health production function. In addition, p (0) = +∞ so that positive amount will be spent on
health care in equilibrium, and the survival probability tends to p0+p as the health investment
tends to inﬁnite. Here, p can be interpreted as measuring the state of medical technology: An
increase in p not only makes health production more eﬀective, it also raises the maximum
amount of life extension achievable through health investment.8
7We choose γ < 1 in the utility function in part because of the technical problem that we discussed earlier
with negative utilities. This type of utility function with γ < 1 is commonly used to imply a positive interest
rate elasticity of savings. Our results in this section, including simulation, are qualitatively the same if we
assume some alternative functions for u(·) and v(·), such as a logarithmic function for u(·) and a linear function
for v(·).
8Therefore, an increase in p can be thought as capturing both improvement on conventional treatment as
well as discovery of new treatment.
8Under the above speciﬁcations, equation (13) becomes
p(mt)(1 + rt)

ct
t+1
−γ = p (mt)

ct
t+1
1−γ
1 − γ
.
Utilizing (9), (10), and (15), we have
st =( 1− γ)
p(mt)2
p (mt)
≡ s(mt). (19)
Since p(mt) is increasing and concave, it is clear that s(mt) is an increasing function, conﬁrming
the claim in Proposition 1. With the utility function given in (16), making use of (14) and
(15), the ﬁrst order condition (11) becomes
1
[f(kt) − ktf (kt) − st − mt]γ = p(mt)1+γf (st)1−γ
s
γ
t
(20)
where f(·) and p(·) are given by (17) and (18), respectively. The following result establish a
link between health care and per-capita income.
Proposition 2 In equilibrium, health investment mt is a normal good, that is, it is increasing
with respect to wage income wt and capital labour ratio kt, if α < 1/2.
We again refer the readers to the appendix for the proof. The parameter α represents
the share of capital income in total output. The widely-cited value for α in the empirical
literature is around one third or ranges from 0.25 to 0.4 (see, e.g., Mankiw, Romer, and Weil,
1992). Therefore, α < 1/2 is hardly a restriction. Several implications follow from Proposition
2. First, it conﬁrms the empirical studies mentioned in the introduction that health care is
indeed a normal good. Thus, as a country prospers, health care sector expands. Second,
since the life expectancy increases with the health care spending, Proposition 2 implies that
rich countries have longer life expectancy than poor ones. This prediction accords well with
the empirical evidence (see Table 1). Third, population aging emerges in our model as a
by-product of the process of economic development. As our model economy develops, agents
consume more health care services and hence a greater percentage of the population survives
to their old age, leading to population aging. While the association of population aging and
economic development has been widely observed (see, again, Table 1), our explicit channel of
health care in a dynamic general equilibrium framework is new.9
9We should add that it is not our position to suggest that this is the only, or even the most important,
operative channel for observed population aging. For example, many studies have associated population aging
with falling fertility.
9One of the key questions that we would like to investigate with the present model is the
overall eﬀect of health care in the process of economic growth: Does health care promote or
retard output? Health care consideration is typically absent in various neoclassical growth
models. We can gain some understanding of the impact of such omission in conventional mod-
els, as well as the eﬀect of health care on growth, by comparing our model with a benchmark
model that is otherwise identical except without the health care sector. In our model, the
equilibrium dynamics are determined by the initial per-capita capital stock k0, (10), (19), and
(20). A steady state of this economy is then characterized by st = kt = k and mt = m for
all t. Under certain regularity conditions, it can be shown that the dynamics of this economy
always converge to a unique steady state.10 In the absence of the health care sector, the health
investment is forced to be zero, i.e., mt =0 , and hence the survival probability is constant
pt = p0.E q u a t i o n( 2 0 )t h e nb e c o m e s
1
[f(kt) − ktf (kt) − st]γ = p
1+γ
0
f (st)1−γ
s
γ
t
(20 )
Thus, the equilibrium dynamics in the benchmark model are determined by the initial per-
capita capital stock k0, (10), and (20 ). It can be shown that this benchmark model has a
unique, globally stable steady state. The question of whether the steady state output in our
model with health care is higher than that in the benchmark model is in fact not trivial:
Although Propositions 1 and 2 establish a positive interaction between health care and capital
accumulation, health care spending on the other hand diverts resources from goods production
and hence lowers the potential output in the economy. To see which eﬀect of health care will
dominate in the long run and other comparative statics, we now turn to simulation.
3.1 Simulation
We choose the following parameter values in our base case simulation: p0 =0 . 2 ,p =0 .6, α =
1/3, γ =0 .5 and A =1 0 .T h ec h o i c eo ft h eb a s ec a s ev a l u eo fα =1 /3 i sb a s e do nw i d e l y - c i t e d
empirical estimate of the income share of capital, such as in Mankiw et al (1992). In our
model, the probability p0 measures the default likelihood of surviving to old age when health
care spending is nil. This can be approximated by the surviving probability to age 65 (the
retirement age) in the poorest countries. Since, according to the World Bank Development
Indicators 2001, this probability in some poorest countries ranges from 0.2 to 0.4 (for example,
10For instance, these properties of uniqueness and stability of the steady state always hold for the ranges of
various parameter values that are used in our simulation exercise.
10this probability for Sierra Leone is 0.22), we choose p0 =0 .2 for our base case. In addition,
given that the world-wide surviving probability to age 65 is around 0.70 according to the same
source, p =0 .6 seems to be a reasonable starting point.11 The other parameter values are
chosen somewhat arbitrarily and calibrated only to the extent that the range of the resulting
steady-state share of GDP in health care matches that observed in Table 1. We will, however,
perform sensitivity checks with respect to the parameter values for robustness.
We will primarily conduct two kinds of simulation exercises with our model. First, we want
to study whether our model with endogenous health care spending leads to higher or lower
steady-state per capita income and welfare, comparing with the conventional model in which
the role of health care in reducing mortality is absent. Second, we would like to examine how
changes in medical technology (as measured by p)a ﬀect, both qualitatively and quantitatively,
the steady state values of endogenous variables such as per capita income, welfare, health care
expenditure, and survival probability to retirement age.
Our simulation results are summarized in Table 2. The ﬁrst column simply shows the
diﬀerent values of p, which is the proxy for the state of medical technology, we use in simulation.
The second and third columns simply show the corresponding steady-state values of total health
care expenditure as percentage of GDP, m/f(k), and survival probability, p(m), respectively.
In the fourth column, since young agents are the only workers in the economy, GDP per
worker is simply measured by f(k) in the steady state. By including the old people in the
economy who are not in the labor force, the ﬁfth column calculates the GDP per capita by
f(k)/(1+p(m)). Finally, the sixth column shows the (expected) steady state welfare measured
by u(c1)+p(m)v(c2), where c1 and c2 are the ﬁrst- and second-period consumption levels of an
representative agent in the steady state. The corresponding values of GDP per worker, GDP
per capita, and welfare for the benchmark model (p = p0)a r el i s t e di nt h eﬁrst row of Table 2
for the purpose of comparison.
[Insert Table 2 about here]
The reason that we choose the model with p = p0 as the benchmark is two fold. First,
in the conventional models with constant mortality, health care is not considered and its role
in reducing mortality ignored. The comparison between our model and the one with p = p0
captures the general equilibrium eﬀects of introducing health care as an endogenous choice
11The combination of p0 =0 .2 and p =0 .6 implies that the state of medical technology allows for a surviving
probability to the retirement age of up to 0.8 in our model.
11variable in a growth context. Second, following Ehrlich (2000) to interpret p = p0 as the
“natural”, or “biological”, mortality rate, our comparison then suggests the aggregate impact
of deliberate eﬀort in inﬂuencing “nature” through health care spending. One immediate result
from Table 2 is that the steady-state values of GDP per worker, GDP per capita, and welfare
are decidedly higher in our model with health care than their counterparts in the benchmark
m o d e lf o rt h eb a s ec a s e . 12 This conclusion is robust with respect to the state of medical
technology and a wide range of other parameter values (see Table 3) as well as alternative
model speciﬁcation (where agents work in both periods). This oﬀers a direct support to the
hypothesis that health care is indeed growth and welfare enhancing. Put diﬀerently, this result
suggests that the empirical studies of growth that do not treat health care as an explicit
choice variable tend to either underestimate growth or overestimate the roles of other factors
in production. Quantitatively, the table shows that the eﬀects of incorporating health care into
the benchmark model are economically signiﬁcant. For example, depending on the available
medical technology, investment in health stock could potentially improve both the steady-state
GDP per capita and welfare by as much as about 60% over the benchmark levels.
Table 2 also shows the eﬀects of medical technology. An advance of medical technology,
i.e., an increase in p, leads to increases in all variables listed in Table 2. Consequently, medical
advancement is not just a cause for humanitarian concern, it is also of real economic importance.
In fact, the economic impact of improving medical technology in our model is quite signiﬁcant.
Pushing the longevity boundary of p from 0.1 to 0.8 can bring about 50% increase in per capita
GDP and welfare.13 Naturally, the potency of continuing improvement in medical technology
declines as the diminishing returns in both goods production and health production kick in.
For instance, an increase of p from 0.1 to 0.2 leads to about 13% rise in per capita GDP,
while an increase of p from 0.7 to 0.8 only leads to roughly 1.4% rise in per capita GDP.
Furthermore, the simulation results in Table 2 exhibit a positive association between health
expenditure to GDP ratio and medical technology. Such a relationship is rather intuitively:
Medical advancement introduces greater incentives to spend on health care by raising the
marginal productivity of health production, leading to a higher health expenditure to GDP
12Notice that a higher level of GDP per worker does not necessarily imply a higher level of GDP per capita
or welfare. Since a higher steady state k is associated with a greater m,i t se ﬀect on the level of GDP per capita
f(k)/(1 + p(m)) is, a priori, uncertain. Similarly, it is not obvious that the level of welfare associated with
higher k and m is indeed greater.
13This result is consistent with the recent work by Murphy and Topel (1999), in which they concluded that
the social gains from medical research are derived mainly from prolongation of life expectancy and likely to be
enormous.
12ratio. Therefore, the observed cross-country pattern in health care expenditure in Table 1 can
be potentially, or partially, explained by the diﬀerent states of medical technology available in
c o u n t r i e sa c r o s sd i ﬀerent income groups.
Closer examination of Table 1 reveals that the diﬀerence in health care spending to GDP ra-
tio between low and middle income countries is relatively small (4.5% and 5.0%, respectively),
comparing with that between low/middle and high income countries (8.9% among EMU coun-
tries). Matching our simulated health care shares in Table 2 with the data requires a p value
of roughly 0.15, 0.18, and 0.6 for low income, middle income, and EMU countries, respectively.
This would suggest that while the medical technology gap between low and middle income
countries is small, EMU/high income countries possess a signiﬁcant lead in this regard. This
implication seems to ﬁt quite well with the casual observation that, while some basic medical
technology is readily available all over the world, more advanced and sophisticated medical
p r a c t i c e sa r em o s t l yu s e di nh i g hi n c o m ec o u n t r i e s .
We have also carried out sensitivity analysis of the simulation results discussed above.
Varying exogenous parameters within wide ranges of values produced similar results that only
diﬀer quantitatively. We are, therefore, reasonably conﬁdent that our core analysis and results
on the relationship between health care and economic growth in the present paper are quite
robust in the qualitative sense. We report some of our sensitivity analysis results in Table
3.14 The sensitivity results with respect to p0 reported in Table 3 are perhaps particularly
interesting. Other than serving as regular robustness checks, these results also show the quan-
titative diﬀerence between our model with endogenous life expectancy and the conventional
model where the changes in longevity are treated as exogenous. These results support our main
ﬁnding that the exclusion of health care in the analysis will underestimate the steady state
income and welfare, and thus health investment is indeed growth promoting.
[Insert Table 3 about here]
We should note that while our model is capable of closely matching the data on health
care spending to GDP ratio in diﬀerent income groups under reasonable parameter values,
the simulated survival probabilities in Table 2 are systematically lower than the corresponding
14We have also performed simulations with various combinations of the parameters other than those reported
in Table 3, and with the inclusion of an explicit discount factor for the second-period utility. In all instances,
the simulation results remain qualitatively similar to those in Table 3. In addition, since a deﬁnite retirement
age may not exist in some countries, we have also checked that our simulation results survive, in fact become
stronger, in the extension where agents work in both periods.
13probabilities of survival to age 65 observed in Table 1 for similar values of health expenditure
share in GDP. One plausible reason of this bias is because we assume that the survival prob-
ability is only aﬀected by spending on medical products and services but totally unrelated to
consumption activities and/or other external factors. Presumably, how much food, and what
food, we consume would heavily inﬂuence our health and hence the chances of survival.15 More
importantly, various food and health aid programs by international organizations to a country
can have a visible impact on the mortality rate in the country. These eﬀects are likely to be
signiﬁcant for poor countries where adequate nutrition intake is not guaranteed and advanced
medical knowledge is lacking. In fact, Preston (1976, 1980) found that various aid programs,
both in kind and in medical know-how, had played an important role in the mortality declines
in the post-World War II developing countries. Since we did not take into account of these
programs in our model, it is not surprising to see that the under-estimation of the survival
probability in our simulation is more pronounced for the low/middle income countries.16
Another caveat regarding our simulation results is that the order of diﬀerences in per-
capita GDP observed in Table 2 between countries with diﬀerent health expenditure shares
are noticeably smaller than their counterparts in real life. This may be partly due to the
fact that all countries in our model share the same production technology while, in reality,
more advanced countries are likely to have a higher total factor productivity measured by A.
Overall, the main focus of the present paper is to highlight the potential importance of health
care through a simple, partially calibrated model, perhaps at the expense of sacriﬁcing certain
degree of realism in other dimensions.
4C o n c l u d i n g R e m a r k s
In spite of the signiﬁcance of health care expenditure in many advanced countries, its implica-
tion on economic growth has rarely been formally analyzed. In this paper, we have examined
the inter-dependence between health care and economic development in a general equilibrium
framework. Contrasting to the previous studies, the present paper has endogenized life ex-
pectancy through the choice of health care spending. We have shown in our model that health
15One justiﬁcation we can perhaps venture here is that the overall health eﬀect of a consumption bundle may
be negligible, as the potential good and bad health eﬀects of diﬀerent goods we consume oﬀset each other in a
wash.
16However, transfers of medical resources and technology from abroad can be likened to increases in p0 in
our model. As such, the sensitivity analysis regarding p0 in Table 3 provides some indication to the impacts of
medical aid programs.
14care and savings are complements in that they rise and fall together along a development
path. Moreover, health care is likely to be a normal good at the aggregate level. Therefore,
in the context of economic development, our model is able to replicate several stylized facts
observed in the data, namely, (i) countries spend more on health care as they prosper, (ii) rich
countries have on average longer life expectancy, and (iii) population aging as measured by the
proportion of elderly population is more pronounced in rich countries.
Comparing to an otherwise identical benchmark model with a constant life expectancy,
our simulation showed that health care is growth promoting as well as welfare improving:
The steady-state GDP per worker, GDP per capita, and welfare in our model are consistently
higher than their respective counterparts in the benchmark model. This growth- and welfare-
improving impact of health care is particularly interesting because it is achieved despite that
health care spending brings a greater dependency ratio (population aging) in the economy.
Furthermore, the diﬀerence between the two models, for instance in per capita income, can be
signiﬁcant where the medical technology is advanced and eﬀective in extending lives. This sug-
gests that, missing the consideration for health investment, the estimation of the conventional
models could be severely biased. Our simulation also revealed that countries with more ad-
vanced medical technology converge to steady states with higher per-capita income and higher
health care share in GDP.
As a ﬁrst pass to formally analyze the role of health care in the growth framework, we have
chosen indeed a very simple neoclassical model in the present paper. In our model, the positive
eﬀects of health care on output and welfare arise from increased savings due to prolonged life
expectancy. In reality, there are likely to be other positive eﬀects of health that are not captured
here. For example, health improvement may increase work eﬃciency as well as extend working
years of individuals. We expect accounting for these considerations would only reinforce our
central thesis in the present paper. On the other hand, our model has also abstracted from
some interesting issues that can potentially complicate the current analysis. For example, we
have not considered alternative approaches to health care provision such as health insurance
or public health sector. A health insurance scheme would require some pay-as-you-go type of
inter-generational transfers, which may cause large-than-optimal premiums for the young due
to the distorted incentives of the old under the health insurance; while a public health system
ﬁnanced by income tax would introduce ineﬃciencies due to the distortionary nature of the
tax. Extensions in these directions, however, deserve further research.
15Appendix
Proof of Proposition 1: Ignoring the time subscript and substituting (9) and (15) into (13),
we have
p(m)v 

sf (s)
p(m)

f (s)=p (m)v

sf (s)
p(m)

.
Diﬀerentiating both sides with respect to m and denoting c =
sf (s)
p(m) ,o n eo b t a i n s
p (m)v (c)f (s)+p(m)

v  (c)f (s)

f (s)+sf  (s)
p(m)
ds
dm
−
p (m)
p(m)2

+ v (c)f  (s)
ds
dm

= p  (m)v(c)+p (m)v (c)

f (s)+sf  (s)
p(m)
ds
dm
−
p (m)
p(m)2

.
Rearranging the above equation yields
p (m)v (c)f (s) − v  (c)f (s)
p (m)
p(m)
− p  (m)v(c)+p (m)v (c)
p (m)2
p(m)2
=

p (m)v (c) − p(m)v  (c)f (s)

f (s)+sf  (s)
p(m)

− v (c)f  (s)

ds
dm
.
It is then clear that ds
dm > 0 under the assumption (A) and the properties of functions f(·),
v(·), and p(·).
Proof of Proposition 2: From (22), (24) and (25), they imply
1
[f(kt) − ktf (kt) − s(mt) − mt]γ = p(mt)1+γs(mt)−γf (s(mt))1−γ
=( αA)
1−γ p(mt)1+γs(mt)−γs(mt)(α−1)(1−γ)
=( αA)
1−γ p(mt)1+γs(mt)α(1−γ)−1
=
(αA)
1−γ
(1 − γ)1−α(1−γ) ·
p (mt)1−α(1−γ)
p(mt)(1−2α)(1−γ)
Suppose that kt rises and mt falls. It is clear that the left hand side of the above equation
will decrease. However, since α, γ ∈ (0,1), the right hand side will increase if α < 1
2. The
contradiction completes the proof.
16References
[1] Barro, Robert, 1997. Determinants of Economic Growth. Cambridge, Mass.: The MIT
Press.
[2] Blackburn, Keith and Giam Pietro Cipriani, 2002. “A model of longevity, fertility and
growth,” Journal of Economic Dynamics and Control 26, 187-204.
[3] Bloom, D.E., D. Canning, and B. Graham, 2002. “Longevity and life cycle savings,”
Working Paper 8808, NBER.
[4] Cochrane A.L., A.S. St Leger, and F. Moore, 1978. “Health service ‘input’ and mortality
‘output’ in developed countries,” Journal of Epidemiology & Community Health 32(3),
200-205.
[5] Ehrlich, Isaac, 2000. “Uncertain lifetime, life protection, and the value of life saving,”
Journal of Health Economics 19(3), 341-367.
[6] Ehrlich, Isaac and Hiroyuki Chuma, 1990. “Model of the demand for longevity and the
value of life extension,” Journal of Political Economy 98(4), 761-782.
[7] Ehrlich, Isaac and Francis T. Lui, 1991. “Intergenerational trade, longevity, and economic
growth,” Journal of Political Economy 99(5) 1029-1059.
[8] Gerdtham, U.G., J. Søgaard, B. Jönsson and F. Anderson, 1992. “A pooled cross-section
analysis of the health care expenditures of the OECD countries,” Zweifel,-Peter; Frech,-H.-
E., III, eds. Health Economics Worldwide. Developments in Health Economics and Public
Policy series, vol. 1, Norwell, Mass. and Dordrecht: Kluwer Academic Press, 287-310.
[9] Grossman, Michael, 1972. “On the concept of health capital and the demand of health,”
Journal of Political Economy 80(2), 223-255.
[10] Kelemli Ozcan, Sebnem, Harl E. Ryder, and David N. Weil, 2000. “Mortality decline,
human capital investment, and economic growth,” Journal of Development Economics
62, 1-23.
[11] Kotlikoﬀ, Laurence J., 1989. “Some economic implications of life-span extension,” in What
Determines Savings?. Cambridge, Mass. and London: MIT Press, 358-374.
[12] Lee, R. D., A. Mason, and T. Miller, 2000. “Life cycle saving and the demographic tran-
sition in East Asia,” Population and Development Review 26 (Supplement), 194-222.
[13] Lucas, Robert E., 1988. “On the mechanics of economic development,” Journal of Mone-
tary Economics 22, 3-42.
[14] Mankiw, N. Gregory, David Romer, and David N. Weil, 1992. “A contribution to the
empirics of economic growth,” Quarterly Journal of Economics 107(2), 407-437.
17[15] Murphy, Kevin M. and Robert Topel, 1999. “The economic value of medical research,”
The University of Chicago Working Paper.
[16] Parkin, David, Alistair McGuire, and Brian Yule, 1987. “Aggregate health care expendi-
tures and national income: is health care a luxury good?” Journal of Health Economics
6(2), 109-127.
[17] Philipson, Tomas J. and Gary S. Becker, 1998. “Old-age longevity and mortality-
contingent claims,” Journal of Political Economy 106, 551-573.
[18] Preston, Samual H., 1976. “The changing relation between mortality and level of economic
development,” Population Studies 29, 231-248.
[19] Preston, Samual H., 1980. “Causes and consequences of mortality declines in less devel-
oped countries during the twentieth century,” Easterlin, R. ed., Population and Economic
Change in Less Developed Countries. Chicago: University of Chicago Press, 289-361.
[20] van Zon, Adriaan and Joan Muysken, 2001. “Health and endogenous growth,” Journal of
Health Economics 20, 169-185.
18 
 
 
 
 
 
Table 1: Data selected from World Development Indicators 2001 
 
 
 
Health expenditure
% of GDP
a 
Life expectancy
at birth (years)
b 
Survival to age 65 
  Male
c      Female
c 
Population aged 65
and above
d 
World  5.5 66  65  73  6.7 
Low income countries  4.5 59  55  60  4.2 
Low/middle countries  4.8 64  62  69  5.5 
Middle income countries  5.0 69  68  78  6.6 
High income countries  9.7  78  81  91            14.0 
EMU countries  8.9  78  80  91            15.9 
 
a Average over the period of 1990-1998 
 
b For cohort born in 1999 according to the age-specific mortality rate 
 
c Percentage of cohort born in 1999 who would survive to age 65 according to the age-specific mortality rate 
 
d Percentage of total population in 1999 
 
 
 
 
 
 
 
 
Table 2: Summary of simulation results 
 
Other parameters:  , .2 0 0 = p   , .33 0 = α   , .5 0 = γ   10 = A  
p   Health expenditure 
% of GDP 
Survival      
probability 
GDP           
per worker 
GDP           
per capita 
Steady state     
welfare 
Benchmark  0.00  0.20  6.39 5.33 5.31 
0.1  3.14  0.24  7.27 5.85 5.65 
0.2  5.78  0.32  8.65 6.57 6.21 
0.3 7.27  0.39  10.03  7.19  6.75 
0.4 8.14  0.48  11.34  7.68  7.24 
0.5 8.66  0.56  12.56  8.04  7.67 
0.6  8.98  0.65  13.67  8.31  8.05 
0.7 9.15  0.73  14.69  8.49  8.38 
0.8 9.25  0.82  15.62  8.61  8.66 
 
 
 
 
 
 
 
 
  
 
Table 3: Sensitivity analysis 
 
Other parameters:  , .2 0 0 = p   , .6 0 = p   , .5 0 = γ   10 = A  
 Benchmark  Model  Our  Model 
α   Survival 
probability 
GDP per 
capita 
Steady state 
welfare 
Survival 
probability 
GDP per 
capita 
Steady state 
welfare 
0.25 0.2 6.02 5.74  0.63 7.38 7.60 
0.30 0.2 5.62 5.49  0.64 7.90 7.86 
0.33 0.2 5.33 5.31  0.65 8.31 8.05 
0.35 0.2 5.18 5.21  0.65 8.53 8.15 
0.40 0.2 4.69 4.89  0.65 9.28 8.46 
 
 
Other parameters:  , .2 0 0 = p   , .6 0 = p   , .33 0 = α   10 = A  
 Benchmark  Model  Our  Model 
γ   Survival 
probability 
GDP per 
capita 
Steady state 
welfare 
Survival 
probability
GDP per 
capita 
Steady state 
welfare 
0.1  0.2  6.47 6.71 0.61 8.73 9.57 
0.3  0.2  5.86 5.59 0.63 8.52 8.37 
0.5  0.2  5.33 5.31 0.65 8.31 8.05 
0.7  0.2  4.85 6.25 0.67 8.04 9.33 
0.9 0.2 4.42  13.78  0.71  7.31  19.90 
 
 
Other parameters: , .2 0 0 = p   , .6 0 = p   , .33 0 = α   5 0. = γ  
 Benchmark  Model  Our  Model 
A  Survival 
probability 
GDP per 
capita 
Steady state 
welfare 
Survival 
probability
GDP per 
capita 
Steady state 
welfare 
1  0.2  0.17 0.94 0.27 0.19 1.03 
5  0.2  1.88 3.15 0.54 2.78 4.40 
10  0.2  5.33 5.31 0.65 8.31 8.05 
15  0.2  9.79 7.19 0.69  15.59  11.30 
20  0.2 15.06  8.92 0.71  24.28  14.31 
 
 
Other parameters:  , .6 0 = p   , .33 0 = α   5 0. = γ   10 = A  
 Benchmark  Model  Our  Model 
0 p   Survival 
probability 
GDP per 
capita 
Steady state 
welfare 
Survival 
probability
GDP per 
capita 
Steady state 
welfare 
0.10 0.10 3.49 3.88 0.55 7.93 7.50 
0.15 0.15 4.50 4.66 0.60 8.14 7.79 
0.20 0.20 5.33 5.31 0.65 8.31 8.05 
0.25 0.25 6.01 5.86 0.69 8.45 8.29 
0.30 0.30 6.58 6.35 0.74 8.56 8.50 
 Appendix I
(For reference only, not intended for publication)
In this appendix, we present some aggregate data to justify the theoretical formulation used
in our model of the relationship between health care spending and the survival probability to
old age. We extract the data on health expenditure per capita, survival rate to age 65, and life
expectancy at birth for 133 countries from World Development Indicators 2001 compiled by
the World Bank. To avoid unnecessary noise, we examine the group averages of those variables
by dividing the 133 countries equally into ten groups (percentiles) according to their health
expenditures per capita in PPP$, with Group 1 containing countries that have the lowest and
Group 10 containing countries that have the highest health expenditures per capita. Table A
lists the group averages of these variables. The scatter plots in Figure A clearly support our
speciﬁcations of the function p(m) in the model.
Table A: Mortality indicators and health expenditures 
  Health expenditure Life expectancy  Survival to age 65 (%)*
 
Countries  per capita (PPP$)  at birth (years)  Male  Female  Average 
Group 1  24 46  33  39  36 
Group 2  42 52  41  46  44 
Group 3  68 56  48  54  51 
Group 4  98 64  60  69  65 
Group 5  170 65  61  72  66 
Group 6  256 68  65  75  70 
Group 7  362 69  64  79  71 
Group 8  592 71  68  82  75 
Group 9  1,193 76  78  88  83 
     Group 10#  2,171 78  82  91  86 
 * Percentage of newborns who would survive to age 65 according to current age-specific mortality rate 
# Group 10 contains 3 more countries than other groups, in order to exhaust the full sample of countries 
 
Figure A: Mortality indicators and health expenditures 
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 Appendix II
(For reference only, not intended for publication)
The purpose of this appendix is to show that our analysis in the present paper can be readily
extended to a model in which individuals work in both periods when young and old. The life
time utility for an individual is rewritten as
U(ct
t,c t
t+1)=u(ct
t)+p(mt)v(ct
t+1) (A1)
where ct
t = wt − st − mt and ct
t+1 = wt+1 + st(1 + rt)+τt with τt = 1−Pt
Pt st(1 + rt).F o r
illustration, we will continue using our parametric model in Section 3 with equations (21),
(22), and (23). The ﬁrst order conditions with respect to st and mt are:

ct
t+1
ct
t
γ
= p(mt)(1 + rt) (A2)

1
ct
t
γ
= p (mt)

ct
t+1
1−γ
1 − γ
. (A3)
Since wt =( 1− α)Akα
t and 1+rt = αAkα−1
t+1 ,i tf o l l o w st h a tct
t+1 =
k
(1 − α)+ α
p(mt)
l
Asα
t .
Then, making use of the capital market clearing condition
kt+1 = st, (A4)
we can solve from (A2) and (A3) that
st =
α(1 − γ)
[α +( 1− α)p(mt)]

p(mt)2
p (mt)

. (A5)
It is easy to verify from (A5) that st is an increasing function of mt so that they are, again,
complements in equilibrium. After algebraic manipulation, (A3) becomes
1
[(1 − α)Akα
t − st − mt]
=
αα(1−γ)A1−γ
(1 − γ)1−α(1−γ) ·
[α +( 1− α)p(mt)]
(1−α)(1−γ) p (mt)1−α(1−γ)
p(mt)(1−2α)(1−γ) .
(A6)
The dynamical system is fully determined by (A4), (A5), and (A6) for any given k0.W eh a v e
performed simulations on this system and found that, for example, the results reported in Ta-
ble 2 are qualitatively similar. In fact, in all instances, the simulated steady-state output per
capita and welfare are even higher in the extended model than those in our main model. Intu-
itively, when agents are working in both periods, the entire population is equally productive.
Therefore, the eﬀect that rising life expectancy would raise the proportion of unproductive
population is missing, leading to higher output per capita and welfare in the steady state.